Testing effectiveness (Phase 2)Looking for participantsNCT05363280
What this trial is testing
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
Who this might be right for
Small Cell Lung CancerRenal Cell Carcinoma (RCC)Non-Small Cell Lung
Advenchen Pharmaceuticals, LLC. 80